Using the Case Study of Atezolizumab Development to Rethink Early Phase Oncology Trial Design
Using the Case Study of Atezolizumab Development to Rethink Early Phase Oncology Trial Design
Frontiers in Biostatistics Seminar Tuesday February 14, 2023 1:00PM Eastern Time YouTube video Emily Zabor, DrPH Assistant Staff Biostatistician Department of Quantitative Health Sciences at the Cleveland Clinic, with a joint appointment in the Taussig Cancer Institute Assistant Professor of Medicine, the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University